Integrins are transmembrane receptors that play important roles as modulators of cell behaviour through their adhesion properties and the initiation of signaling cascades. The a IIb integrin subunit (CD41) is one of the first cell surface markers indicative of hematopoietic commitment. a IIb pairs exclusively with b 3 to form the a IIb b 3 integrin. b 3 (CD61) also pairs with a v (CD51) to form the a v b 3 integrin. The expression and putative role of these integrins during mouse hematopoietic development is as yet unknown. We show here that hematopoietic stem cells (HSCs) differentially express a IIb b 3 and a v b 3 integrins throughout development. Whereas the first HSCs generated in the aorta at midgestation express both integrins, HSCs from the placenta only express a v b 3 , and most fetal liver HSCs do not express either integrin. By using a IIb deficient embryos, we show that a IIb is not only a reliable HSC marker but it also plays an important and specific function in maintaining the HSC activity in the mouse embryonic aorta.
Introduction
Hematopoietic stem cells (HSCs) are at the foundation of the blood system and are the key cell type in transplantation protocols for blood-related disorders. The number of HSCs available for clinical applications and fundamental research is limited. The efficient expansion and/or generation in vitro is thus far not possible because our knowledge of the mechanisms underlying HSC growth, including the specific in vivo interactions between HSCs and the surrounding microenvironment are poorly understood.
Adult HSCs are generated only during a short window of developmental time (Boisset and Robin, 2012) . They are first detected at embryonic day (E)10.5 of mouse development in the Aorta-Gonad-Mesonephros (AGM) region (Medvinsky and Dzierzak, 1996; Müller et al., 1994) . Starting at E11, HSCs are also found in the yolk sac (YS), placenta (PL) and fetal liver (FL). The pool of HSCs expands in the PL and FL before colonizing the bone marrow (BM) from E17 onward (Gekas et al., 2005; Ottersbach and Dzierzak, 2005) . Studies performed in the zebrafish, chicken and mouse models have clearly demonstrated that HSCs originate from specialized endothelial cells referred as hemogenic (Boisset and Robin, 2012) . HSCs most likely reside in clusters of cells (Intra-Aortic Hematopoietic Clusters, IAHCs) that are tightly attached to the endothelium of the aorta, the vitelline and umbilical arteries, and the vascular labyrinth of the placenta (Rhodes et al., 2008; Yokomizo and Dzierzak, 2010) . In adult BM, HSCs localize in specialized niches that maintain the balance between HSC self-renewal, quiescence and differentiation. Adhesion molecules (including integrins) are important for the binding of HSCs to the BM niches (Grassinger et al., 2009; Notta et al., 2011; Potocnik et al., 2000; Qian et al., 2006; Umemoto et al., 2006; Wagers and Weissman, 2006) . In contrast to adult, the specific interactions and cell adhesion properties of HSCs in the aorta and the successive developmental niches are as yet poorly described.
Integrins are transmembrane glycoproteins (gp) that play an important role in cell adhesion, survival, proliferation, differentiation, migration, gene regulation, and cytoskeletal arrangement. They are a family of 24 heterodimeric receptors composed of a (18 types) and b (8 types) subunits (Prowse et al., 2011) . While some integrins are ubiquitously expressed, others are tissue-or cell lineage-specific (Bouvard et al., 2001) . Adult HSCs express several integrins important for homing and migration (e.g. a 4 b 1 , a 5 b 1 , a 6 b 1 ) (Bonig et al., 2009a; Bonig et al., 2009b; Grassinger et al., 2009; Lapidot et al., 2005) . In the embryo, a IIb (platelet (gp)IIb or CD41) is one of the earliest surface markers of hematopoietic commitment (Emambokus and Frampton, 2003; Ferkowicz et al., 2003; McKinney-Freeman et al., 2009; Mikkola et al., 2003; Mitjavila-Garcia et al., 2002; Robin et al., 2011) and its expression is developmentally regulated. E11 AGM HSCs express a IIb , whereas HSCs in the E12 AGM, E12 PL or E14 FL are a IIb negative (Matsubara et al., 2005; McKinney-Freeman et al., 2009; Robin et al., 2011) . By performing time-lapse confocal imaging on live mouse embryo slices, we have shown that the onset of a IIb expression coincides with the formation of hematopoietic stem/progenitor cells (HSPCs) from the hemogenic aortic endothelium Boisset et al., 2010) and that a IIb protein localizes at the point of contact between the cells in IAHCs.
To date little is known about integrin function and expression in HSCs throughout development. The BM of a IIb deficient mice show no hematopoietic lineage commitment problems (TronikLe Roux et al., 2000) but possess defective platelets and display bleeding disorders similar to those seen in b 3 deficient mice (Hodivala-Dilke et al., 1999) and humans with Glanzmann thrombasthenia disease. Here we examine the expression of a IIb , b 3 and a v integrin subunits on HSCs in the main hematopoietic sites (AGM, YS, PL, and FL) and the function of a IIb in these cells. a IIb exclusively associates with b 3 to form the major platelet integrin a IIb b 3 (gpIIb/IIIa or CD41/CD61). b 3 also associates with a v to form the a v b 3 integrin (CD51/CD61). We show by performing in vivo transplantation assays of sorted populations that newly generated E11 AGM HSCs express a IIb b 3 integrins whereas HSCs from E12 PL and E14 FL do not. a v b 3 is expressed on all AGM and PL HSCs but on only a few E14 FL HSCs. All three types of HSCs were found in the E12 YS. Interestingly, a IIb deficient embryos show an HSC defect in the AGM but not in the YS and FL, indicating that a IIb plays a fundamental and precise spatio-temporal role to maintain the HSC activity in the aorta of the mouse embryo.
Materials and Methods

Mice and embryo generation
Embryos were generated from crosses of hb-globin ln72 mice and wild-type (C57BL/106CBA)F1 females; Ly5.1 males and females; a IIb +/tk males and a IIb +/+ or a IIb +/tk females; a IIb tk/tk males and a IIb +/+ or a IIb +/tk females; wild-type C57BL/6 females and males. The day of vaginal plug observation is embryonic day (E)0. ln72, YMT and a IIb genotypes were determined by DNA PCR. Mice were housed according to institutional guidelines and all animal procedures were carried out in compliance with the Standards for human care and use of laboratory animals.
Dissections and cell preparation
E11-E14 embryos were isolated. Tissues (AGM, FL, YS, PL) were dissected and dissociated as previously described (Robin and Dzierzak, 2005) . Viable cells were counted (using trypan blue) and kept in phosphate-buffered saline (PBS), 10% fetal calf serum, and penicillin/streptomycin (PBS/FCS/PS) at 4˚C for further analysis.
Explant culture
Whole AGMs were cultured as explants at 37˚C for 3 days as previously described (Medvinsky and Dzierzak, 1996) . Explant cultures of a IIb mutant AGMs were performed with no added cytokines. To test the number of CD41 int CD61 int CD45 int ckit + cells per wild-type AGM, the medium was supplemented or not with 200 ng/ml of recombinant murine IL-3 (Robin et al., 2006) or 250 ng/ml of gremlin (Durand et al., 2007) .
Hematopoietic progenitor assay
In vitro hematopoietic progenitor analysis was performed on dilutions of sorted cells plated in triplicates in methylcellulose medium (StemCell Technologies). Plates were incubated at 37˚C in a humidified chamber under 5% CO 2 . Hematopoietic colonies were counted with an inverted microscope at day 12 of the culture.
In vivo transplantation assay and transplanted mice analysis
Intravenous injection of total or sorted cells into irradiated adult wild-type recipients was as previously described (Robin et al., 2006) . Recipient female mice ((129/SV6C57BL/6), C57BL/6 or (CBA6C57BL/10)) were exposed to a split dose of 9 Gy of c-irradiation ( 137 Cs source) and injected with several cell doses (or embryo equivalent, ee). 2610 5 spleen cells (recipient background) were coinjected to promote short-term survival.
Blood was obtained at 1 and 4 months post-transplantation and DNA was analyzed for donor cell markers by semiquantitative PCR (hb-globin, a IIb , Ymt).
The percentage of donor contribution was calculated from a standard curve of DNA control dilutions (0 to 100% donor marker). Recipients were considered repopulated when the chimerism was greater than 10%. For multilineage repopulation analysis, thymus, lymph nodes, bone marrow and spleen were dissected from the repopulated recipients. T, B, erythroid, and myeloid cells were sorted from recipient BM and spleens after antibody staining (see below). Primary recipient BM cells were injected into secondary irradiated recipients to assess selfrenewal capacity (0.5610 6 or 2610 6 cells injected per recipient; supplementary material Fig. S4D ). Chimerism level of the Ly5.2 recipients (C57BL/6) injected with Ly5.1 cells was determined by flow cytometry (see below). Recipients were considered repopulated when the chimerism was greater than 5%.
For statistical analysis, student's t test (Mann-Whitney) was used to determined statistical significance.
Flow cytometric analysis and sorting
Flow cytometric analysis and sorting were performed on a FACScan and/or AriaIII (BD Bioscience) with CellQuest and FACSDiva. Stainings were performed in PBS/FCS/PS for 30 min at 4˚C. Cells were washed and resuspended in PBS/FCS/ PS and 7-AAD (Molecular Probes, Leiden, NL) or Hoechst 33258 (1 mg/ml, Molecular Probes) for dead cell exclusion. The positive gates were defined from staining with isotype-matched control antibodies. Monoclonal antibodies (BD Pharmingen, eBioscience, Invitrogen, Santa Cruz, Biolegends) used: FITC-antiTer119, FITC-anti-CD42c (Gp1bb); PE-anti-CD41; APC-anti-CD61; FITC, APCCy7 or APC-AlexaFluor750-anti-c-kit; FITC, PE or PE-Cy7-anti-CD31; PerCPCy5.5-anti-CD45; APC or Pacific Blue-anti-CD34; Alexa-Fluor488-anti-CD51; Lin cocktail (PE-anti-Ter119, PE-anti-B220, PE-anti-Mac1, PE-anti-Gr1, PE-antiCD3e); PE-anti-CD48; APC-anti-CD150 and PE-Cy7-anti-Sca-1.
Ly5.2/Ly5.1 cell chimerism was determined by flow cytometry on blood after erythrocyte lysis (Beckman Coulter) and staining with FITC-anti-Ly5.2, PE-antiLy5.1 and 7-AAD. Flow cytometry data were analyzed with FlowJo.
For multilineage repopulation analysis, spleen cells were stained with FITCanti-B220, PE-anti-CD8a and PE-anti-CD4; bone marrow cells were stained with FITC-anti-Ly6C and PE-anti-CD31.
Cell cycle analysis
Cells from dissociated E11 AGM were stained with PE-anti-c-kit antibody. Cells were washed prior to fixation with 2% PFA for 30 min. Cells were then permeabilized for 1 h in 0.2% Triton X-100. After washing, cells were incubated during 1 h with FITC-anti-Ki-67 antibody or IgG isotype control. Cells were washed and incubated with Hoechst 33342 (1 mg/ml, Molecular Probes) prior to analysis by flow cytometry.
Pre-apoptosis analysis
Cells from dissociated E11 AGM were stained with PE-anti-c-kit antibody. Cells were washed in cold PBS and resuspended in 16 binding buffer (10 mM Hepes/ NaOH, pH 7.4, 140 mM NaCl, 2.5 mM CaCl 2 ) and stained for 20 min with Annexin-V-FITC and Hoechst 33258 (1 mg/ml, Molecular Probes). Analyses were performed within 1 h by flow cytometry.
Whole-mount immunostaining
The whole-mount immunostaining was performed as previously described (Yokomizo and Dzierzak, 2010) . Rat anti-mouse primary antibodies for c-Kit (2B8) and biotinylated anti-CD31 (MEC13.3) were used (BD Biosciences). Secondary antibodies were goat anti-rat IgG-Alexa647 (Invitrogen) and streptavidin-Alexa594 (Invitrogen). Embryo caudal halves were imaged using a Leica SP5 confocal microscope.
Staining and confocal microscopy of non-fixed embryo and placenta slices
Non-fixed wild-type embryos were cut into thick transversal slices (200 mm) and stained with directly conjugated monoclonal antibodies as previously described Boisset et al., 2010) . The antibodies include: PE-anti-CD41 (MWreg30), Alexa488-anti-CD51 (RMV-7), APC-anti-CD61. Similarly, placentas isolated from E12 non-fixed wild-type embryos were cut into slices (200 mm) and were incubated with PE-anti-Tie-2, Alexa488-anti-CD51 (RMV-7) and APC-anti-CD61. Slices were immobilized into agarose gel and imaged by using a Leica SP5 confocal microscope.
Results
Hematopoietic stem cells differentially express a IIb b 3 and a v b 3 integrins throughout development
HSCs are restricted to the CD41 intermediate (CD41 int ) fraction in E11 AGM (McKinney-Freeman et al., 2009; Robin et al., 2011) . However, HSCs in E12 AGM and PL, and E14 FL are exclusively in the CD41 2 fraction. In YS, HSCs are in both populations . To further investigate integrin subunit expression on HSCs, we performed flow cytometric analyses for a v (CD51) and b 3 (CD61), in addition to a IIb (CD41) expression. Cells were analysed at the time points corresponding to organ-specific peaks of HSC activity and subunit expression was found to differ between tissues ( Fig. 1 ). CD41 int CD61 2 cells were found only in E11 AGM (Fig. 1A) , and not in E12 YS (Fig. 1C ), E12 PL (Fig. 1E ) or E14 FL (Fig. 1G ).
CD41
2 CD61 high cells were found mainly in E12 PL ( Fig. 1E ) and to a lesser extent in E11 AGM (Fig. 1A) Further enrichment of the E11 AGM CD41 int CD61 int population was attempted with the pan-hematopoietic marker CD45 and the HSC marker c-kit (Sánchez et al., 1996) . All committed cells from erythroid (Ter119 + ) and megakaryocytic (Gp1bb + ) lineages were first excluded (supplementary material Fig. S2A, left panel) and the CD41 int CD61 int HSC containing fraction (Fig. 1A,B ) was sorted into four subfractions: CD45 Fig.  S2C, right panel) . These cells provided high-level multilineage reconstitution of the primary and secondary transplanted recipients (supplementary material Fig. S2B) Fig. S2D,E) . This is consistent with our previous findings that IL-3 is a powerful amplifying factor (Robin et al., 2006) and Gremlin (a BMP antagonist) is an inhibitory factor for HSC activity in E11 AGM (Durand et al., 2007; Robin and Durand, 2010 To determine the precise location of cells expressing a IIb , a v and/or b 3 , multicolour stainings were performed using the technique that we previously developed to stain non-fixed embryo slices . We observed CD41
int cells in the IAHCs of E10.5 embryos ( Fig. 2A) . Interestingly, the integrin subunits were concentrated at the junction between the IAHC cells.
The embryo slice staining technique was adapted to non-fixed PL. E12 PL slices stained with directly labelled anti-Tie-2 antibodies (Fig. 2B) showed specific staining of both placental vessels and umbilical artery (UA). This allowed discrimination of the chorionic plate (C), the vascular labyrinth (L) and the spongiotrophoblast layer (S) (Fig. 2B ). To localize phenotypically defined HSCs in the Tie-2 + placental vessels (FV), multicolour staining was performed with anti-CD51 and CD61 antibodies (Fig. 2C) . Groups of CD51 int CD61 int cells were observed in the vasculature of the chorionic plate and similar to the aorta, the integrin subunits were concentrated at the junctions between cells (Fig. 2C) 2000) were isolated and tested in the colony forming unit-culture assay (CFU-C; n53). As shown in Fig. 3A , AGMs of E11 mutant embryos contained erythroid and myeloid progenitors. The numbers of total CFU-C and of each type of progenitor were similar in the mutants as compared to wild-type AGMs, demonstrating that a IIb does not influence the production or function of AGM progenitors.
Whole embryo imaging of a IIb +/+ , a IIb +/tk and a IIb tk/tk E11 embryos immunostained for CD31 (to visualize endothelial and IAHC cells) and c-kit (to visualize IAHC cells) revealed no differences in IAHC cell number (Fig. 3B) , organization or shape (Fig. 3C,D 
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Dzierzak, 1996). We tested whether a IIb deficient HSCs can be maintained and expanded in AGM explant cultures (n53). Cells from a IIb +/tk or a IIb tk/tk AGM explants were able to reconstitute 13% and 20% of the transplanted recipients, as compared to 100% of recipients transplanted with cells from a IIb +/+ AGM explants (Fig. 4B) . As expected the HSC repopulation ability of the a IIb +/+ AGM cells was higher after explant culture, as compared to transplantations performed without pre-culture (Fig. 4A) . In contrast the HSC repopulation ability of the a IIb mutant AGM cells was significantly lower. This was not due to abnormal cycling or increased apoptosis of c-kit + cells in the a IIb mutant AGM (supplementary material Fig. S5A,B, respectively) . Altogether, the results support a role for a IIb in the maintenance of AGM HSC repopulating activity.
a IIb deficient embryos have no major hematopoietic stem cell defect in the YS or FL HSC activity of a IIb mutant YSs was also tested (only some YS HSCs express a IIb ). Transplantations with YS cells isolated from E11 a IIb +/+ , a IIb +/tk and a IIb tk/tk embryos (n53) showed similar percentages of mice reconstituted (28%, 22% and 20%, respectively) at four months post-transplantation (Fig. 4C) . Thus, while there is a strong HSC defect in the AGM of the a IIb mutant embryos, it is not the case in the YS.
Similarly, we performed transplantations with FL cells isolated from E11 a IIb +/+ , a IIb +/tk and a IIb tk/tk embryos (n54), at the time when HSCs start to colonize the FL. The percentage of reconstituted mice after the injection of a IIb +/tk or a IIb tk/tk cells (25%) was similar to the percentage of reconstituted mice after the injection of a IIb +/+ cells (14%) (Fig. 4D ) thus showing that a IIb mutant HSCs are able to migrate and colonize the FL in vivo.
We further tested the HSC activity in the FL of a IIb mutant embryos at E14, a time point when HSCs extensively expand. 
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Discussion
The a IIb integrin subunit (CD41) is one of the first surface markers indicative of hematopoietic commitment (Ferkowicz et al., 2003; McKinney-Freeman et al., 2009; Mikkola et al., 2003; Robin et al., 2011) . It is notably expressed by the first hematopoietic cells emerging from the hemogenic endothelium in the aorta (Boisset et al., 2010) . We found here that a IIb is not only a reliable HSC marker, but it also plays an important role in maintaining HSC activity in the aorta.
We have also found that HSCs differentially express a IIb , b 3 and a v integrin subunits during ontogeny. Since HSCs in embryos are difficult to identify in situ, integrin expression can be used in combination with other markers (as CD45 and c-kit) to enrich and localize HSCs throughout development. Surprisingly, a substantial fraction of HSCs in the E11/E12 YS do not express a IIb and/or b 3 integrin subunits. Such HSCs are not detectable in the AGM at the same time point, the YS might generate such a subset of HSCs. The results of in vivo CD41-Cre-mediated genetic tagging suggest that all/most HSCs go through an a IIb expressing phase, as is reflected by a high percentage of labelled hematopoietic cells in the adult animals (35-65%) (Rybtsov et al., 2011) . Thus, the expression of integrins on the surface of HSCs appears to not only be IAHC cells express a IIb (Corbel and Salaün, 2002; Yokomizo and Dzierzak, 2010) . Due to low expression levels, the visualization of CD41 by immunostaining embryo cryosections is rather difficult and often is in the context of high background. However, our results show that immunostaining of non-fixed embryo slices with directly conjugated antibodies allows the visualization of low level of integrin expression in the aorta with good resolution Boisset et al., 2010) . We observed that IAHC cells co-express a IIb , b 3 and a v . Interestingly, a IIb , b 3 and a v were mainly localized at the junction between the cells that form the IAHCs. Using this improved technique to immunostain viable PL slices, we were also able to observe the placental vasculature and groups of HSPCs expressing both a v and b 3 in the vasculature of the chorionic plate. Similar to the IAHCs, a v and b 3 were mainly at the junctions between the cells.
We have previously shown that hematopoietic progenitors in the E11 AGM and YS are CD41 int , whereas they are in both CD41 2 and CD41 int fractions in E12 PL and E14 FL . To test whether a IIb plays a role in the progenitor activity in the AGM, we examined a mouse line (a IIb tk/tk ) in which the a IIb locus was disrupted by the integration of a tk gene, resulting in the lack of a IIb protein expression (Tronik-Le Roux et al., 2000) . We observed no differences in the total number or types of progenitors in the AGM of E11 a IIb +/+ , a IIb +/tk , or a IIb tk/tk embryos. Such results indicate that a IIb does not play a role in the regulation of the hematopoietic progenitors in the AGM region. This is in contrast to a study in which the disruption of a IIb results in an increased number of hematopoietic progenitors (CFUMyeloid, BFU-E and CFU-Mk) in E9.5 YS, and in E12.5, E13.5 and E15.5 FL (Emambokus and Frampton, 2003) . This difference in the requirement for a IIb on progenitors might depend on the resident microenvironment. Thus, a IIb does not play a functional role on the progenitors despite the fact that all progenitors express this marker in the AGM . We observed fewer HSCs and a decrease in the HSC activity in the AGMs of a IIb mutant embryos. The few remaining HSCs were found to be functional in transplantation experiments, ruling out the possibility that a IIb mutant AGM HSCs are defective in homing to the adult BM niche. Interestingly, we did not find differences in the HSC activity in a IIb mutant YS and FL at the same time point of development (E11). The HSC activity was also normal at a later stage (E14), when HSC expansion occurs in the FL, indicating that a IIb mutant HSCs can undergo normal expansion. The HSC defect is thus restricted to the AGM region. The HSC activity was also lower after explant culture of the a IIb mutant AGMs showing that HSC activity is not maintained in the AGM when a IIb is absent. The defect seems to be cell intrinsic since only IAHC cells (where HSCs reside) express a IIb in the aorta at this stage of development. The observation that the HSC defect is similar in the AGMs in both a IIb +/tk and a IIb tk/tk embryos suggests that a certain threshold of a IIb on the surface of HSCs might therefore be necessary to maintain the HSC activity in the AGM.
We found in a IIb mutant embryos that the number of c-kit + IAHC cells and the shape of the IAHCs are similar to that in wild-type embryos. Thus, either a IIb does not play a role in IAHC cell anchorage, or other adhesion molecules compensate for the absence of a IIb (e.g. a v b 3 ). The normal number of IAHCs also shows that a IIb , which is expressed by the emerging IAHCs and HSCs, is not required for the endothelial to hematopoietic transition (EHT). Integrin binding to extra-cellular matrix compounds induces outside-in signaling through clustering of integrin heterodimers at focal adhesion sites (Gong et al., 2010; Hynes, 2002) . This will recruit other cell surface receptors and many proteins that will activate intracellular signaling pathways. Therefore, the absence of a IIb might have direct or indirect consequences, resulting for example in the lack of recruitment of important receptors to the focal adhesion points (e.g. cytokine receptors) or the lack of signaling downstream of a IIb b 3 integrins. It was shown that platelet clot formation is mediated through phosphorylation of the c-Src kinase (regulating downstream effectors such as RhoA) after binding of a IIb b 3 to the Ga 13 subunit (Gong et al., 2010) . It was also recently shown that outside-in signaling via pY747 of b 3 (b 3 PY747) following activation of a v b 3 integrin by TPOmediated inside-out signaling is indispensable for TPOmediated maintenance of HSC activity in vitro and in vivo within the BM niche (Umemoto et al., 2012) . Whether such mechanisms are also active on E11 AGM HSCs will be the focus of further investigations.
Altogether our study shows that b 3 and a v integrin subunits, in addition to a IIb , are reliable markers of the first HSCs found in the AGM. Such subunits are then differentially expressed by HSCs throughout embryonic development and can be used to isolate and localize HSCs. It has been shown that some integrin subunits are important for the retention of HSPCs in the adult BM niches (e.g. a 4 (Scott et al., 2003) ) and/or for the colonization of HSPCs into the FL and BM (e.g. b 1 (Hirsch et al., 1996; Potocnik et al., 2000) ). Here we highlight a new role for integrin subunits and provide evidence that a IIb is important to maintain the HSC activity in the aorta.
